Wang H H, McIntosh A R, Hasinoff B B, Rector E S, Ahmed N, Nance D M, Orr F W
Department of Pathology, Faculty of Medicine, University of Manitoba, Winnipeg, Canada.
Cancer Res. 2000 Oct 15;60(20):5862-9.
The formation of liver metastases involves interactions between intravascular cancer cells and the hepatic microvasculature. Here we provide evidence that the arrest of intravascular B16F1 melanoma cells in the liver induces a rapid local release of nitric oxide (NO) that causes apoptosis of the melanoma cells and inhibits their subsequent development into hepatic metastases. B16F1 melanoma cells (5 x 10(5)) labeled with fluorescent microspheres were injected into the portal circulation of C57BL/6 mice. The production of NO in vivo was detected by electron paramagnetic resonance spectroscopy ex vivo using an exogenous NO-trapping agent. A burst of NO was observed in liver samples examined immediately after tumor cell injection. The relative electron paramagnetic resonance signal intensity was 667 +/- 143 units in mice injected with tumor cells versus 28 +/- 5 units after saline injection (P < 0.001). Two-thirds of cells arrested in the sinusoids compared with the terminal portal venules (TPVs). By double labeling of B16F1 cells with fluorescent microspheres and a TdT-mediated UTP end labeling assay, we determined that the melanoma cells underwent apoptosis from 4-24 h after arrest. The mean rate of apoptosis was 2-fold greater in the sinusoids than in the TPVs at 4, 8, and 24 h after injection (P < 0.05-0.01). Apoptotic cells accounted for 15.9 +/- 0.8% of tumor cells located in the sinusoids and 7.1 +/- 0.9% of tumor cells in the TPVs. The NO synthase inhibitor N(G)-nitro-L-arginine methyl ester completely blocked the NO burst (P < 0.001) and inhibited the apoptosis of B16F1 cells in the sinusoids by 77%. However, the rate of tumor cell apoptosis in the TPVs was not changed. There were 5-fold more metastatic nodules in the livers of N(G)-nitro-L-arginine methyl ester-treated mice (P < 0.05). The inactive enantiomer N(G)-nitro-D-arginine methyl ester had no effect on the initial NO burst or on apoptosis of tumor cells in vivo. Both annexin V phosphatidylserine plasma membrane labeling and DNA end labeling of apoptotic cells were demonstrated after a 5-min exposure (a time equivalent to the initial transient NO induction in vivo) of B16F1 cells to a NO donor in vitro. These results identify the existence of a natural defense mechanism against cancer metastasis whereby the arrest of tumor cells in the liver induces endogenous NO release, leading to sinusoidal tumor cell killing and reduced hepatic metastasis formation.
肝转移的形成涉及血管内癌细胞与肝微血管之间的相互作用。在此,我们提供证据表明,血管内B16F1黑色素瘤细胞在肝脏中的滞留会诱导一氧化氮(NO)的快速局部释放,这会导致黑色素瘤细胞凋亡,并抑制其随后发展为肝转移瘤。将用荧光微球标记的B16F1黑色素瘤细胞(5×10⁵个)注入C57BL/6小鼠的门静脉循环。使用外源性NO捕获剂,通过电子顺磁共振光谱法在体外检测体内NO的产生。在注射肿瘤细胞后立即检查的肝脏样本中观察到NO的爆发。注射肿瘤细胞的小鼠中相对电子顺磁共振信号强度为667±143单位,而注射生理盐水后为28±5单位(P<0.001)。与终末门静脉(TPV)相比,三分之二的细胞滞留在肝血窦中。通过用荧光微球对B16F1细胞进行双重标记和TdT介导的UTP末端标记试验,我们确定黑色素瘤细胞在滞留后4至24小时发生凋亡。在注射后4、8和24小时,肝血窦中凋亡的平均速率比TPV中的高2倍(P<0.05 - 0.01)。凋亡细胞占位于肝血窦中的肿瘤细胞的15.9±0.8%,占TPV中肿瘤细胞的7.1±0.9%。NO合酶抑制剂N(G)-硝基-L-精氨酸甲酯完全阻断了NO的爆发(P<0.001),并使肝血窦中B16F1细胞的凋亡减少了77%。然而,TPV中肿瘤细胞的凋亡速率没有改变。在N(G)-硝基-L-精氨酸甲酯处理的小鼠肝脏中,转移瘤结节多5倍(P<0.05)。无活性对映体N(G)-硝基-D-精氨酸甲酯对初始NO爆发或体内肿瘤细胞凋亡没有影响。在体外将B16F1细胞暴露于NO供体5分钟(相当于体内初始短暂NO诱导的时间)后,证实了凋亡细胞的膜联蛋白V磷脂酰丝氨酸膜标记和DNA末端标记。这些结果确定了一种针对癌症转移的天然防御机制的存在,即肿瘤细胞在肝脏中的滞留诱导内源性NO释放,导致肝血窦肿瘤细胞死亡并减少肝转移瘤的形成。